{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:24:52Z","timestamp":1793917492666,"version":"4.8.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001819","name":"International Rett Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["HHSN-271-2013-00030"],"award-info":[{"award-number":["HHSN-271-2013-00030"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111151","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T14:40:43Z","timestamp":1787409643000},"page":"111151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploration of the therapeutic potential of the HRH3 histamine receptor in MECP2-related disorders"],"prefix":"10.1016","volume":"300","author":[{"given":"Kelly","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7020-8347","authenticated-orcid":false,"given":"Sheryl A.D.","family":"Vermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geanne","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9272-0539","authenticated-orcid":false,"given":"Shalini","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mac J.","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco G.","family":"Gogliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Niswender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111151_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"232","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2026.111151_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.1988.tb04841.x","article-title":"H3-receptors control histamine release in human brain","volume":"511","author":"Arrang","year":"1988","journal-title":"J. Neurochem."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2026.111151_bib3","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1097\/00004424-198809001-00017","article-title":"Highly potent and selective ligands for a new class H3 of histamine receptor","volume":"23","author":"Arrang","year":"1988","journal-title":"Investig. Radiol."},{"key":"10.1016\/j.neuropharm.2026.111151_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s11689-015-9127-4","article-title":"Anxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scales","volume":"71","author":"Barnes","year":"2015","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2026.111151_bib5","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/hmg\/ddp181","article-title":"Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus","volume":"1813","author":"Ben-Shachar","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2026.111151_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbr.2012.12.063","article-title":"The histamine H(3)-receptor inverse agonist pitolisant improves fear memory in mice","volume":"243","author":"Brabant","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111151_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","article-title":"The physiology of brain histamine","volume":"636","author":"Brown","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111151_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s11689-022-09432-2","article-title":"Anxiety-like behavior and anxiolytic treatment in the Rett syndrome natural history study","volume":"141","author":"Buchanan","year":"2022","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2026.111151_bib9","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"3205880","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.111151_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"4687321","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111151_bib11","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1021\/acschemneuro.2c00113","article-title":"Optimized administration of the M4 PAM VU0467154 demonstrates broad efficacy, but limited effective concentrations in Mecp2(+\/-) mice","volume":"1313","author":"Cikowski","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111151_bib12","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice","volume":"1321","author":"Collins","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2026.111151_bib13","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2147\/NDT.S371483","article-title":"Rett syndrome and MECP2 duplication syndrome: disorders of MeCP2 dosage","volume":"18","author":"Collins","year":"2022","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.neuropharm.2026.111151_bib14","article-title":"Efficacy of pitolisant on the treatment of narcolepsy: a systematic review","volume":"137","author":"Fabara","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.neuropharm.2026.111151_bib15","first-page":"86","article-title":"BP-294 ste civile bioprojet","volume":"11","author":"Fozard","year":"2000","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.neuropharm.2026.111151_bib16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.neuropharm.2009.03.011","article-title":"JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition","volume":"568","author":"Galici","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111151_bib17","article-title":"Histamine H(3) receptor isoforms: insights from alternative splicing to functional complexity","volume":"147","author":"Gao","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2026.111151_bib18","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/stem.1950","article-title":"Inhibition of miR-15a promotes BDNF expression and rescues dendritic maturation deficits in MeCP2-Deficient neurons","volume":"335","author":"Gao","year":"2015","journal-title":"Stem Cell."},{"key":"10.1016\/j.neuropharm.2026.111151_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/jpet.117.246991","article-title":"Total RNA sequencing of Rett syndrome autopsy samples identifies the M4 muscarinic receptor as a novel therapeutic target","volume":"3652","author":"Gogliotti","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuropharm.2026.111151_bib20","article-title":"mGlu7 potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome","volume":"9403","author":"Gogliotti","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111151_bib21","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/hmg\/ddw074","article-title":"mGlu5 positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndrome","volume":"25","author":"Gogliotti","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2026.111151_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41572-024-00568-0","article-title":"Rett syndrome","volume":"101","author":"Gold","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuropharm.2026.111151_bib23","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"3155815","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.111151_bib24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"273","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2026.111151_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2015.10.029","article-title":"Loss of MeCP2 in parvalbumin-and somatostatin-expressing neurons in mice leads to distinct Rett syndrome-like phenotypes","volume":"884","author":"Ito-Ishida","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111151_bib26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40272-023-00575-w","article-title":"Pitolisant: pediatric first approval","volume":"254","author":"Keam","year":"2023","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.neuropharm.2026.111151_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrd1631","article-title":"The histamine H3 receptor: from gene cloning to H3 receptor drugs","volume":"42","author":"Leurs","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2026.111151_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2053-8871-1-5","article-title":"Histaminergic afferent system in the cerebellum: structure and function","volume":"1","author":"Li","year":"2014","journal-title":"Cerebellum Ataxias"},{"key":"10.1016\/j.neuropharm.2026.111151_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"254","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.neuropharm.2026.111151_bib30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14199","article-title":"Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders","volume":"5","author":"Meng","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.111151_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1017\/S0317167100004960","article-title":"Nalpha-methyl histamine safety and efficacy in migraine prophylaxis: phase III study","volume":"332","author":"Millan-Guerrero","year":"2006","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111151_bib32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neuropharm.2014.02.003","article-title":"Mechanism of the histamine H(3) receptor-mediated increase in exploratory locomotor activity and anxiety-like behaviours in mice","volume":"81","author":"Mohsen","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111151_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.gde.2006.04.009","article-title":"MeCP2 dysfunction in Rett syndrome and related disorders","volume":"163","author":"Moretti","year":"2006","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuropharm.2026.111151_bib34","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1523\/JNEUROSCI.6000-11.2012","article-title":"A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission","volume":"329","author":"Na","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111151_bib35","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"686","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111151_bib36","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","article-title":"Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study","volume":"296","author":"Neul","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.neuropharm.2026.111151_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fnint.2020.00007","article-title":"Metabolic signatures differentiate Rett syndrome from unaffected siblings","volume":"14","author":"Neul","year":"2020","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111151_bib38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/mol.116.104752","article-title":"The histamine H3 receptor: structure, pharmacology, and function","volume":"905","author":"Nieto-Alamilla","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111151_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2125.1993.tb05671.x","article-title":"Effect of an inhaled histamine H3-receptor agonist on airway responses to sodium metabisulphite in asthma","volume":"351","author":"O'Connor","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111151_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1172805","article-title":"Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives","volume":"17","author":"Palmieri","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111151_bib41","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1093\/hmg\/ddw179","article-title":"MeCP2 deficiency results in robust Rett-like behavioural and motor deficits in male and female rats","volume":"2515","author":"Patterson","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2026.111151_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/acn3.52269","article-title":"Comprehensive assessment reveals numerous clinical and neurophysiological differences between MECP2-allelic disorders","volume":"122","author":"Pehlivan","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111151_bib43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.21715","article-title":"Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome","volume":"666","author":"Ramocki","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111151_bib44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/ajmg.a.33184","article-title":"The MECP2 duplication syndrome","volume":"152A5","author":"Ramocki","year":"2010","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2026.111151_bib45","doi-asserted-by":"crossref","first-page":"21042","DOI":"10.1074\/jbc.M116.731406","article-title":"The histamine H3 receptor differentially Modulates Mitogen-activated protein kinase (MAPK) and Akt signaling in striatonigral and striatopallidal neurons","volume":"29140","author":"Rapanelli","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111151_bib46","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s41593-018-0270-6","article-title":"Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing","volume":"2112","author":"Renthal","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111151_bib47","article-title":"Pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy","volume":"103","author":"Sarfraz","year":"2022","journal-title":"Health Psychol Res"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111151_bib48","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1007\/s13311-022-01254-3","article-title":"Clinical and preclinical evidence for M1 muscarinic acetylcholine receptor potentiation as a therapeutic approach for Rett syndrome","volume":"19","author":"Smith","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2026.111151_bib49","first-page":"e2594","article-title":"Hand stereotypies: lessons from the Rett syndrome natural history study","volume":"9222","author":"Stallworth","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2026.111151_bib50","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1093\/cercor\/bhx282","article-title":"Contextual fear extinction induces hippocampal metaplasticity mediated by metabotropic glutamate receptor 5","volume":"2812","author":"Stansley","year":"2018","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.neuropharm.2026.111151_bib51","article-title":"Medical comorbidities in MECP2 duplication syndrome: results from the international MECP2 duplication database","volume":"95","author":"Ta","year":"2022","journal-title":"Children"},{"key":"10.1016\/j.neuropharm.2026.111151_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.817195","article-title":"Sleep disorders in Rett syndrome and rett-related disorders: a narrative review","volume":"13","author":"Tascini","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111151_bib53","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/humu.23542","article-title":"MECP2 variation in Rett syndrome-An overview of current coverage of genetic and phenotype data within existing databases","volume":"397","author":"Townend","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuropharm.2026.111151_bib54","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14198","article-title":"Restoration of Mecp2 expression in GABAergic neurons is sufficient to rescue multiple disease features in a mouse model of Rett syndrome","volume":"5","author":"Ure","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.111151_bib55","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1261\/rna.080220.124","article-title":"Site-blocking antisense oligonucleotides as a mechanism to fine-tune MeCP2 expression","volume":"3012","author":"Vanderplow","year":"2024","journal-title":"RNA"},{"key":"10.1016\/j.neuropharm.2026.111151_bib56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00335-019-09793-5","article-title":"Treating Rett syndrome: from mouse models to human therapies","volume":"305\u20136","author":"Vashi","year":"2019","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.neuropharm.2026.111151_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109022","article-title":"Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 duplication syndrome","volume":"209","author":"Vermudez","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111151_bib58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pedneo.2011.08.002","article-title":"Rett syndrome: from bed to bench","volume":"526","author":"Weng","year":"2011","journal-title":"Pediatr. Neonatol."},{"key":"10.1016\/j.neuropharm.2026.111151_bib59","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1038\/ncomms4334","article-title":"Histamine H3 receptors aggravate cerebral ischaemic injury by histamine-independent mechanisms","volume":"5","author":"Yan","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111151_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00213-009-1528-1","article-title":"Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic","volume":"2052","author":"Yokoyama","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111151_bib61","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3945\/jn.114.196105","article-title":"Insufficient intake of L-histidine reduces brain histamine and causes anxiety-like behaviors in male mice","volume":"14410","author":"Yoshikawa","year":"2014","journal-title":"J. Nutr."},{"key":"10.1016\/j.neuropharm.2026.111151_bib62","doi-asserted-by":"crossref","first-page":"32155","DOI":"10.1073\/pnas.2008456117","article-title":"Targeting presynaptic H3 heteroreceptor in nucleus accumbens to improve anxiety and obsessive-compulsive-like behaviors","volume":"11750","author":"Zhang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111151_bib63","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuron.2025.10.035","article-title":"Biased histamine signaling selectively gates fat preference","volume":"1143","author":"Zheng","year":"2026","journal-title":"Neuron"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:49:41Z","timestamp":1793915381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":63,"alternative-id":["S0028390826003266"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111151","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of the therapeutic potential of the HRH3 histamine receptor in MECP2-related disorders","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111151"}}